loading

Finanzdaten der Cyclerion Therapeutics Inc-Aktie (CYCN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
14.81%
0.093
0.081 1.806 0.194 -
Operating Expenses
14.76%
1.765
1.538 1.304 1.322 1.384
Benefits Costs and Expenses
100.00%
-
1.51 1.276 0.917 -
Costs And Expenses
16.89%
1.765
1.51 1.276 0.917 -
Operating Income/Loss
14.76%
-1.672
-1.457 0.502 -1.128 -1.384
Nonoperating Income/Loss
4,714%
1.348
0.028 0.028 0.405 0.062
Income/Loss From Continuing Operations Before Tax
106.51%
0.093
-1.429 0.53 -0.723 -1.322
Income/Loss From Continuing Operations After Tax
77.33%
-0.324
-1.429 0.53 -0.723 -1.322
Net Income/Loss
77.33%
-0.324
-1.429 0.53 -0.723 -1.322
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
20.15%
3.071
2.556 0.008 2.526 2.51
Diluted Average Shares
20.15%
3.071
2.556 0.008 2.526 2.51
Basic Earnings Per Share
80.36%
-0.11
-0.56 0.22 -0.29 -0.53
Diluted Earnings Per Share
80.36%
-0.11
-0.56 0.22 -0.29 -0.53
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):